Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 Jun 26;18(6):e0287204. doi: 10.1371/journal.pone.0287204

Evaluation of tarsal injuries in C57BL/6J male mice

Brenda L Kick 1,¤,*, Laura Anderson 2, Rosalinda Doty 1, Christine Wooley 2, Meaghan Dyer 2, Torrian Green 2, Veronica Knickerbocker 2, Zoe Brown 2, Samantha Loeber 3, Janine Wotton 2, Bonnie Lyons 1, Linda Waterman 1, Zoë Bichler 2
Editor: Joohyun Lim4
PMCID: PMC10292699  PMID: 37363910

Abstract

Tarsal joint abnormalities have been observed in aged male mice on a C57BL background. This joint disease consists of calcaneal displacement, inflammation, and proliferation of cartilage and connective tissue, that can progress to ankylosis of the joint. While tarsal pathology has been described previously in C57BL/6N substrains, as well as in STR/ort and B10.BR strain, no current literature describes this disease occurring in C57BL/6J mice. More importantly the behavioral features that may result from such a change to the joint have yet to be evaluated. This condition was observed in older male mice of the C57BL/6J lineage, around the age of 20 weeks or older, at a frequency of 1% of the population. To assess potential phenotypic sequela, this study sought to evaluate body weight, frailty assessment, home cage wheel running, dynamic weight bearing, and mechanical allodynia with and without the presence of pain relief with morphine. Overall mice with tarsal injuries had significantly higher frailty scores (p< 0.05) and weighed less (p<0.01) compared to unaffected mice. Affected mice had greater overall touch sensitivity (p<0.05) and they placed more weight on their forelimbs (p<0.01) compared to their hind limbs. Lastly, when housed with a running wheel, affected mice ran for a shorter length of time (p<0.01) but tended to run a greater distance within the time they did run (p<0.01) compared to unaffected mice. When tested just after being given morphine, the affected mice performed more similarly to unaffected mice, suggesting there is a pain sensation to this disease process. This highlights the importance of further characterizing inbred mouse mutations, as they may impact research programs or specific study goals.

Introduction

Recently tarsal injuries have been noted in the C57BL/6N background strains from the International Mouse Phenotyping Consortium (IMPC) (www.mousephenotype.org), which is developing genetically altered mice to study mammalian gene function [1]. At the different phenotyping centers, abnormal tarsal joints were noted at various rates in group housed male mice, ranging from 1.7% up to 12%, and beginning from 4 weeks of age to 78 weeks. Similar to the spontaneous ankle deformities in STR/ort mice and ankylosing enthesopathy in B10.BR strain, this condition was not found in females of the same strain and age, or in singly housed males or males in breeding groups [2, 3]. The exact reasons for why there is such a wide range of ages and total percentage of the population affected between the IMPC remains to be known. Some hypotheses may be microbiome differences between the institutions, housing and animal care regime differences, or background differences (some of the mice were from Charles River Laboratories lineage, some from Taconic lineage, and some of the mice had Jackson Laboratory lineage). Due to the reported finding of abnormal tarsal joints in the C57BL/6N colony within the IMPC’s Knockout Mouse Program at The Jackson Laboratory, this facility further observed their aged C57BL/6J colony. Abnormal tarsal joints were noted in older male mice of the C57BL/6J lineage, around the age of 20 weeks or older, at a frequency of 1% of the population. Like previously reported strains, aged matched female mice were not noted to have any tarsal or other joint abnormalities.

Currently this is the first known report of calcaneal dislocation occurring specifically in the C57BL/6J strain. This study sought to assess the potential phenotypic sequela resulting from this disease. With the C57BL/6J mouse being the most widely used background strain in research laboratories, it is important to understand and describe potential research variables that exists in inbred strains. To fully evaluate this disease in C57BL/6J mice, lesions were examined via computed tomography imaging, histologic examination, and mice underwent a variety of behavioral tests to determine the behavioral phenotypes of affected mice. Furthermore, with the inclusion of a morphine treatment group, we went on to determine if this disease is associated with pain in mice, or if their behavioral differences were purely due to their conformational change.

Materials and methods

Mice

Male C57BL/6J mice (JR 000664), aged 45–55 weeks, were bred and housed at The Jackson Laboratory in accordance with AAALAC international accreditation (accreditation number 00096) and the Guide for the Care and Use of Laboratory Animals standards (OLAW assurance D16-00170). All experimental procedures were approved by the Institutional Care and Use Committee (protocol number 99101) at The Jackson Laboratory. Mice were group housed (no more than 2 mice per cage) in micro isolation cages on individually ventilated racks (THOREN Caging Systems, INC), with aspen shavings, with cage sanitation occurring on an every-2-week basis. Reverse osmosis, acidified water and a standard autoclaved rodent diet (Purina Lab Diet 5K52) were provided ad libitum. Routine health monitoring confirmed mice were free of viral antibodies, parasites, and opportunistic organisms [S1 Table]. Environmental conditions were maintained at 68 to 72°F (20 to 22°C) and 30%-70% humidity with a 12:12-h light: dark cycle (6:00am lights on: 6:00pm lights off). All experimental animals were humanely euthanized with carbon dioxide gas in accordance to the guidelines of the American Veterinary Medical Association.

Experimental design

The colony of mice was observed closely in order to detect affected animals as soon as possible and affected and control mice were selected within a short window of time. A pilot study of 31 male mice, aged 45–55 weeks, were clinically evaluated to have a unilateral tarsal injury, evidenced by a rounded and thickened tarsal joint, abducted joint angle, and reduced range of motion. A total of 70 age matched, unaffected male mice were identified for use as controls. Seven cohorts of affected mice with age matched non-affected mice underwent a battery of behavioral tests.

Frailty composite testing, voluntary wheel running assay, von Frey test, and the dynamic weight bearing test were conducted in that order, with at least 1-day rest in between tests. After behavioral testing a subset of mice were imaged via computed tomography and histopathology of affected and unaffected joints was evaluated.

After the pilot study, another group of male mice (n = 75), aged 45–55 weeks, that were clinically evaluated to have a unilateral tarsal injury and age matched, unaffected male control mice (n = 41) were selected for a follow up pain study. A battery of behavioral tests was performed without morphine: frailty composite testing, von Frey test, and dynamic weight bearing test, with at least 1-day rest in between. After a 7-day rest period between behavioral tests the groups were tested again with a 10 mg/kg dose of morphine sulfate in saline (Sigma, Lot# SLCG0429, Morphine sulfate pentahydrate, Cat. No. M8777-250mg, final concentration 1mg/mL) given via intraperitoneal injection approximately 1h before testing.

Imaging

A total of 10 affected and 13 unaffected age matched males were anesthetized with isoflurane and imaged on the Quantum GX Micro CT (PerkinElmer Health Sciences, Waltham, Massachusetts). All subjects had a single 72mm Field of View (FOV) whole-body scan at 288μm voxel resolution and a single 36mm FOV regional scan at 72μm voxel resolution of the hind limbs. Post scan, subjects were recovered in a clean 37°C heated cage before returning to their home cages.

Histopathology

A total of 10 affected males were evaluated histologically in the affected tarsus and other joint surfaces. The tissue regions of interest were dissected and fixed in 10% neutral buffered formalin (Thermo Fischer Scientific, Fair Lawn, New Jersey) for 48 hours, and then decalcified in Immunocal (StatLab, Columbia, Maryland) for 96 hours. Tissues were then paraffin embedded, sectioned into 5 μm thick sections, and stained with hematoxylin and eosin. Sagittal sections of the tarsus and metatarsophalangeal joints were obtained. Multiple step sections were taken through the joints, ranging from 100 to 300μm between sections. Representative images were acquired using an Olympus BX41 microscope with an Olympus DP72 camera and cellSens Standard 1.5 imaging software. Histopathology evaluations were performed by a board-certified veterinary anatomic pathologist.

Behavioral testing

Before each behavioral procedure, mice were brought into the procedure room, body weights were recorded, and mice were left undisturbed to acclimate to the room for a minimum of 60 minutes. All tests were performed by trained and inter-validated technicians, as blind as possible using BlindID, and in a constant environment during the entire project [room temperature between 68 to 72°F (20 to 22°C)].

Frailty composite test

Mice were individually evaluated for the presence, absence, and severity of 27 categorical variables of wellbeing (scored 0, 0.5, or 1), as well as, body weight and body temperature (Braintree Scientific #TH5 Thermalert) [S2 Table]. Characteristics observed included physical, physiological and innate reflex conditions [4]. For frailty, the experimenters consisted of 4 different females, these were not repeated observations, and so each mouse was only observed by 1 female.

Home cage wheel running

Mice were individually placed in a clean cage equipped with a wireless running wheel (Med Associates, cat. no. ENV-047, components include DIG-807 USB interface hub, SOF-860 Wheel Manager Software, SOF-861 Wheel Analysis Software, and ENV-044-01 Low profile wheel) and the activity of the animals was recorded during a 2 day and 3-night session. Food and water were given ad libitum and daily checks performed. A wireless transponder, synchronized with a computer, recorded the number and time of running wheel revolutions. Data was evaluated for onset of activity, distance traveled (rpm) and time spent running (min). For wheel running the experimenters were 2 different females.

Von frey test

Mice were acclimated for an additional 60-minute period on top of a wire mesh grid. One of a standard set of calibrated microfilaments (0.2 to 2g) was applied to the plantar surface of the hind paw until it bowed and was maintained in place for 3 seconds or until the paw was withdrawn. A positive response was noted as a withdrawal from the microfilament and response to the next lower microfilament were tested, consistent with the “up-down” method, where if no response was observed, then the next highest microfilament in the series is applied. On the highest filament the mouse is offered two opportunities to respond due to the up-down method, in which, once a mouse responds on the highest filament, they are presented with that filament again and if still a response is present the next lower filament is presented until the mouse does not respond to two filaments in a row [5]. For this test the 0.4g filament was the first filament applied in all mice. Both paws were tested subsequently and paw withdrawal threshold (g) is defined as the minimum force applied resulting in withdrawal of the paw. For von Frey, the experimenters were 3 different females.

Dynamic weight bearing

The dynamic weight bearing test (DWB) (BioSeb Dynamic Weight Bearing Instrument) was used to evaluate weight bearing and weight distribution per limb during unencumbered movement. It is an important component of motor abnormality assessment as it provides an underlying understanding of alterations in gait. Mice were weighed and individually placed in a chamber where they could move freely for a 5-minute period. The floor of the apparatus contains 1,936 pressure transducers, video from a high resolution camera mounted above the enclosure is used to corroborate data from the pressure transducers, and the raw data for each paw is synchronized with the images from the video to average the values of the paw weight and surface areas at a sampling rate of 10Hz [6]. For this test our data is based off an n = 64 for mice with tarsal lesions and n = 35 for control mice. This is in part due to not all mice providing the 10 seconds of no movement necessary for the equipment to obtain weight bearing movement. The entirety of the test lasts 300 seconds, in which time the machine needs 10 consecutive seconds of no movement to obtain data. Other part was due to scheduling conflicts and not being able to fit all mice into the testing schedule, resulting in some mice missing their before or after timepoints. In all we had 11 affected mice and 6 controls that we were not able to gather data from our original cohort of mice selected. Dynamic weight bearing experimenters contained 1 female and 1 male observer.

Statistical analysis

Mixed model ANOVA analyses were conducted for the behavioral assays (SPSS software IBM v26) to account for possible cohort and age effects in the experiment. The bodyweight analysis was conducted only on the initial time point (before morphine). For other assays, group (Control vs Affected) was tested as a fixed factor, time-point (Before Morphine or After Morphine) as a repeated fixed factor, with cohort set as a random factor and age as a covariate. There were no significant effects of cohort. The Von Frey data also included the additional comparison of the two hind paws. The running wheel pilot study assay did not include the before/after morphine factor but had the additional fixed factor of light, the interaction of group with light and a repeated measure of the 30-minute binned measures embedded in the lighting condition.

Results

Physical examination

Grossly all affected mice presented with a tarsal joint abnormality in one hind leg, that generated an acute angle to the joint (compared to the normal near 90° angle)(red arrow), which was thick and stiff, inhibiting the ability to perform full extension of this joint (Fig 1A). This condition occurred in only 1% of the total population. The unaffected mouse is imaged (Fig 1B) and the normal near 90 angle to the joint is highlighted by the black arrow. Note how the affected mouse (Fig 1A) has more of the metatarsals planted on the ground compared to an unaffected mouse (Fig 1B) that has more of the phalanges of the feet touching the ground with the metatarsals lifted off the ground.

Fig 1.

Fig 1

Lateral view of a male mouse with the right hind limb tarsal joint affected (A). Showing the acute angle of the joint, with a curved appearance (red arrow). Mice with this joint abnormality have an inability to fully extend the joint which results in them walking more on the metatarsals of the foot compared to a normal mouse (B) pictured on the right. Note the normal right hind limb joint, with normal positioning of the tarsal joint (black arrow) and weight bearing on foot pad.

Imaging

MicroCT in all affected mice revealed an acute angle to the tarsal joint, with severe smoothly marginated new bone at entheses and bridging the joint margins (Fig 2B, 2D and 2E), compared to unaffected mice (Fig 2A and 2C). The joint spaces were narrowed and ill-defined, and the margins of the tarsal bones were indistinct from each other (Fig 2E). The regional soft tissues surrounding the tarsus were circumferentially thickened (Fig 2D solid arrows). Imaging findings were consistent with dislocation of the calcaneus and tarsal ankylosis. Thin, linear mineralization was within the calcaneal tendon of both unaffected and affected mice (Fig 2A–2D).

Fig 2.

Fig 2

Dorsoplantar (left) and lateral (right) radiographs of an unaffected tarsal joint (A) and an abnormal, affected tarsal joint (B). Coronal (left) and sagittal (right) microCT manual planar reformatted images (top) and 3D reconstructed images (bottom) of an unaffected tarsal joint (C) and an abnormal, affected tarsal joint (D). Coronal (left) and sagittal (right) maximum intensity projection images of an abnormal, affected tarsal joint (E). Note the acute angle to the affected tarsal joint. There is a large volume of smoothly marginated mineralization along the periarticular margins of the tarsus including entheses of the distal tibia, tarsal joints, and proximal metatarsus, bridging the joint spaces and tarsal bones (dashed arrows). The soft tissues centered over the affected tarsus were circumferentially thickened, worse plantar (white arrows).

Histopathology

Histopathological examination identified luxation and proximocaudal displacement of the calcaneus, such that the long axis of the calcaneus was nearly parallel to the long axis of the tibia, in all grossly abnormal joints (Fig 3B), when compared to normal orientation in unaffected joints (Fig 3A). There was often partial to complete osteonecrosis of the talus (Fig 3C), which also had histological evidence of subluxation (Fig 3C) in some of the mice. Bone remodeling of the tarsal bones was marked, with periosteal proliferation, large enthesophytes (Fig 3B, 3E and 3G open arrows), osteophytes, cartilaginous to boney metaplasia of the soft tissues (Fig 3E and 3G open arrows), and partial ankylosis. Most affected joints had moderate synovial hyperplasia and mild inflammation and fibrovascular proliferation (Fig 3E and 3G). The articular cartilage between tarsal bones was often smooth or had only mild fibrillation (Fig 3B and 3C evidenced with closed arrows). The overlying skin was usually normal, with no inflammation or ulceration noted (Fig 3B and 3C).

Fig 3.

Fig 3

Lateral view of the tibiotarsal joint of an unaffected paw (A) and affected paws showing displacement of the calcaneus (B) and the talus (C) bones. The calcaneus (star) is displaced proximally and caudally in the affected paw with the long axis nearly parallel to the tibia. The talus (*) of the affected paw (C) is necrotic and the talotarsal joint is subluxated with the talar body rotated cranially and the talar head rotated caudally. Affected joints have extensive fibrocartilaginous proliferation of the joint capsule and ligaments (open arrows) resulting in partial ankylosis. Note that articular cartilage is often essentially normal (solid arrows). Higher magnification views of the tibiotalal joint of unaffected (D, F) and affected (E, G) paws using H&E (D, E) and Safranin O (F, G) stains.

Frailty assessment

The frailty score was calculated as a sum of all sub-scores attributed in several observational, physical, and physiological features. Data are means ± standard deviation. Mice affected by unilateral calcaneal displacement had a significantly lower body weight (mean = 36.03g ± 0.425) compared to controls (38.41g ± 0.575) (p<0.001 age significant covariate p<0.01; F1,113 = 11.1.8, p<0.01) (tested before morphine) (Fig 4). Affected mice displayed a significant increase in frailty score (p<0.05) compared to control mice both before (Affected mean = 5.4 ± 0.2; Control 4.9 ± 0.3; F1,113 = 6.7, p<0.05) and after administration of morphine (Affected 5.3 ± 0.2, Control 4.6 ± 0.3; F1,113 = 19.5, p<0.001) (Fig 5). The results of the pilot data were similar, as affected mice had lower body weights (Affected 36.2 ± 3.7; Control 39.3 ± 4.8; F1,97 = 17.1, p<0.001) and had higher frailty scores (Affected 4.5 ± 0.8; Control 4.1 ± 1.1; F1,96 = 3.9, p = 0.05) compared to control mice.

Fig 4. Bodyweights for the control group (n = 41) and affected group (n = 75), measured at the before-morphine time-point, are displayed as boxplots, showing mean, quartiles with 5–95 percentile error bars.

Fig 4

(** p<0.01).

Fig 5. The frailty scores for the control group (n = 41) and affected group (n = 75) displayed as boxplots, showing mean, quartiles with 5–95 percentile error bars before (*p<0.05) and after (***p<0.001) morphine.

Fig 5

Data are means ± SD.

Home cage wheel running

Home cage wheel running was only performed during the pilot study. Running wheel data was averaged in 30-minute bins and pooled across days in each light condition representing a 24-hour cycle. The total duration of the running wheel experiment was a 2 day and 3 night session. The mean distance travelled and mean time on wheel (in 30 minutes) were recorded for 12 hours of dark and 12 hours of light as 24 bins in each light condition. The mean overall distance travelled by the affected mice was greater than the control mice (F1,11014 = 6.9, p<0.015). More specifically, the interaction of factors revealed that the distance travelled in the dark was significantly greater for the affected group compared to control mice (F1,11014 = 8.7, p<0.01) with no significant differences found in the light. Fig 6A shows that affected mice travelled further in the dark period except for the few bins between 4:30 and 6:00am. In contrast, mean time on the wheel during the dark was significantly lower for affected animals, (F1,11008 = 7.6, p<0.01) than controls with no differences seen in the light. Fig 6B shows that the difference between the groups was more pronounced in the hours before and after light transition.

Fig 6.

Fig 6

A) The mean distance travelled (+/- SEM) for each 30-minute bin is displayed in a 24-hour cycle for the control (n = 70) and affected (n = 31) mice. The yellow box indicates lights on. B) The mean time on the wheel in minutes (+/- SEM) for each 30-minute bin is displayed in a 24-hour cycle (yellow box indicates lights on).

Von frey

To test for hind foot withdrawal threshold, affected mice had both affected and nonaffected feet tested, and control mice had both right and left hind limbs tested. Data was log transformed prior to analysis. Factors of group (Affected vs Control), time (Before and After morphine) and foot (affected vs non affected for Affected and left vs right for Control) were tested. It was predicted that affected would show differences in sensitivity between the feet and the control group would not. This was shown as a significant interaction between group and foot (F2,468 = 9.99, p<0.001). Affected mice showed lowest response threshold on their affected hind limb, with their unaffected limb having a similar threshold to control mice (Fig 7A). The groups also responded differently to morphine (F2,468 = 6.5, p<0.01). After morphine, the affected mice response threshold increased slightly, but still had a lower response threshold than their unaffected limb or compared to the control mice (Fig 7B).

Fig 7.

Fig 7

A) The log transformed force of both hind limbs before morphine administration for the control group (n = 41), and both affected and unaffected hind limbs of the affected group (n = 75) are displayed as boxplots, showing mean, quartiles with 5–95 percentile error bars (***p<0.001). B) The threshold force of both hind limbs after morphine administration for the control group (n = 41), and both affected and unaffected hind limbs of the affected group (n = 75) (**p<0.01).

Dynamic weight bearing

To test for differences in weight bearing, the stance of mice was examined by comparing the load placed on forelimbs and hind limbs. Mean surface area and mean weight load were determined for fore and hind limbs and normalized to body weight. The analysis compared the factors of stance (Fore vs Hind limbs), group (Affected vs Control), and time-point (Before vs after morphine). It was predicted that affected mice would place relatively less load on their hind limbs compared to control mice and this would be shown as an interaction between the factors of stance and group.

The surface area interactions were significant between stance and group (F1,96 = 6.3, p<0.05) and between time, stance, and group (F1,96 = 5.0, p<0.05). The hind limb surface area before morphine for the affected group was lower (mean = 0.57 ± 0.12 mm2) compared to control mice (0.66 ± 0.11; Univariate ANOVA post hoc comparison F1,96 = 13.4, p<0.001), while the forelimb surface area was similar to control mice (Affected 0.33 ± 0.11; Control 0.32 ± 0.11; Fig 8A). However, after morphine, there was no significant difference between the affected (0.53 ± 0.11) and control groups hind limb surface area (0.52 ± 0.09; Fig 8B).

Fig 8.

Fig 8

A) Before morphine surface area fore and hind limb scores for control group (n = 35) and affected group (n = 64) displayed as boxplots, showing mean, quartiles and 5–95 percentile error bars (***p<0.001) 8B). After morphine surface area fore and hind limb scores for control group (n = 35) and affected group (n = 64).

The normalized weight load interactions were significant between stance and group (F1,96 = 4.1, p<0.05) and between stance and time (F1,96 = 12.0, p<0.001). Before morphine, the proportion of the weight load placed on the hind limbs of the affected group (mean = 0.66 ± 0.12), was lower compared to control mice (0.69 ± 0.10; Univariate ANOVA post hoc comparison F1,96 = 4.0, p<0.05; Fig 9A) After morphine, the affected group hind limb weight load proportion increases (0.69 ± 0.12) and is barely lower than the control group (0.71 ± 0.12; Univariate ANOVA post hoc comparison F1,96 = 3.9, p = 0.05; Fig 9B).

Fig 9.

Fig 9

A) Before morphine normalized weight load score for both fore and hind limbs for control group (n = 35) and affected group (n = 64) displayed as boxplots, showing mean, quartiles and 5–95 percentile error bars (p<0.05) B). After morphine normalized weight load score for both fore and hind limbs for control group (n = 35) and affected group (n = 64) (*p = 0.05).

Discussion

This study sought to phenotype mice with unilateral tarsal abnormalities to better understand the potential confound this condition introduces for research subjects and determine if this condition results in nociception. Overall, we only observed this condition in older male mice of the C57BL/6J lineage, around the age of 20 weeks or older, at a frequency of 1% of the population. Moreover, this study demonstrates that mice with unilateral tarsal abnormalities have higher frailty scores, weigh less, bear more weight on their unaffected limbs, have higher touch sensitivity on their affected limb, and run farther in a shorter amount of time compared to unaffected mice. The morphine data suggests that affected mice do experience nociception with this condition, as after morphine treatment, mice were able to bear more weight on their affected limb and their touch sensitivity decreased with the von Frey filaments.

During the behavioral tests with morphine administration our affected mice still did not respond equivalently to our control groups and some avenues of thought include that either their bone structure confirmation difference does affect their behavior, the morphine dose was not at an effective dose for these mice to completely ameliorate nociception, and/or the time window in which we performed the behavioral tests was not within the optimum timeframe for maximum effectiveness. We did utilize a published dose of morphine and stayed within the published effective timeframe, however, morphine doses in mice were published in the ICR mouse strain and strain differences are noted with other drug administrations in mice [7]. Their bone conformation changes likely play a role in some results, such as dynamic weight bearing. Since we measured surface area, we know that the bone conformation causes them to have less surface area on their affected limb. This is why we wanted to evaluate the difference between fore and hind limbs during evaluation so that we could average out their affected and non-affected limbs in the results, compared to most of our data where we utilized their unaffected hind limb as an internal control. Memory may have also played a role in some of the behavioral responses. For instance, with von Frey, while the affected mice showed a decrease in touch sensitivity post morphine administration, they still did not respond equivalently to control mice, which may be due to remembering the prior event and the mechanical nociception that it caused, resulting in an increased touch sensitivity to control mice with morphine. Overall, there were improvements seen in the behavioral responses in the tests we performed, which is a strong indicator that nociception is a sensation for the mice with tarsal abnormalities.

All of the affected mice were at a chronic stage of pathology, so it is not clear how the tarsal pathology started. However, since there was no evidence of pathology in the unaffected joints, the dislocation of the calcaneus may be the initial event, and the resulting joint instability leads to connective tissue and cartilage proliferation, inevitably ending with ankyloses of the joint. The pathologic changes, along with higher frailty scores, lower body weight, lower mean run time during the dark phase, lower response threshold to von Frey filaments, and less weight placed on affected limbs in dynamic weight bearing indicate that mice are unable to respond to various tests in a similar manner as unaffected controls. With the results from the morphine data, in which affected mice showed improvement in their von Frey scores and more evenly distributed weight on dynamic weight bearing is suggestive of this condition having nociceptive properties. With C57BL/6J mice being a common background strain to utilize in genetic manipulations, it is important to identify and characterize any background pathology. This disease may be an unwanted confounding research variable depending on research goals, and therefore, the condition may need to be identified and removed from the research cohorts.

While the exact cause of the tarsal abnormality remains unknown, there are some similarities with other joint diseases noted predominantly in males. Male mice have a higher incidence of osteoarthritis (OA), particularly in the STR/ort strain, and this strain has been also observed to have calcaneal dislocation [3, 8, 9]. Males are also exclusively affected by Ankylosing Enthesopathy (ANKENT), a spontaneous joint disease that begins with development of inflammatory cells at enthesis sites, followed by proliferation of cartilage and connective tissue, and results in or causes ankyloses of the tarsal joint [2, 10, 11]. Similar to the C57BL/6J mice affected in this study, ANKENT occurs in group housed male mice on a C57BL background (most notably the B10.BR strain), and does not develop in singly housed males, breeder males, or females of a similar age range [12, 13]. While OA and ANKENT are two different musculoskeletal disease processes, they are both sexually dimorphic in which similar strains and ages of female mice do not develop these disease, however, it has been noted in both diseases that there is no linkage sex hormones [12]. Group housed males are known to have higher bone mineral density and content, which may be due to their incidence of fighting being 1.3 times higher than group housed females [14, 15]. The increased fighting is likely putting enough strain on the hindlimbs to prompt an osteogenic response [14]. Notably, our microCT scans showed that even in nonaffected aged males, the calcaneal tendons contained small fragments of bone, which may be a result of chronic rearing injuries during fighting events or a result of normal aging degenerative changes. This change was noted as an apparent normal degenerative aging process in both sexes of STR/ort and CBA/ort strains, for mice over the age of 7 months [3].

While the exact cause for this tarsal abnormality remains unknown, it is likely to have a multifactorial cause, similar to ANKENT, in which a combination of genetics, housing condition, and microbial flora all play a role in the disease onset and progression [1013, 16]. An advanced understanding of how tarsal abnormalities affect various behavioral/phenotypic tests will help other institutions or research groups identify this condition and understand that this disease may result in research variables. While in our facility the rate of occurrence in our aged C57BL/6J colony was around 1%, other institutions have reported as high as 12% occurrence dependent on strain and other genetic manipulations, suggesting the important role of the environmental parameters in the development of the disease [1]. Further research to fully understand how this disease develops, and how to prevent it, will help preserve research subjects in line with the 3 R’s of Russell and Birch [17].

Supporting information

S1 Table

(PDF)

S2 Table

(DOCX)

Acknowledgments

The author would like to thank The Jackson Laboratory Center for Biometric Analysis, Scientific Services, and Comparative Medicine and Quality staff for all of their contributions to this body of work. A special thank you to Jacqui White for all of her financial and review support.

Abbreviations

ANKENT

Ankylosing Enthesiopathy

DWB

Dynamic Weight Bearing

MicroCT

Micro Computed Tomography

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Herbert E, Stewart M, Hutchison M, Flenniken AM, Qu D, Nutter LMJ, et al. The occurrence of tarsal injuries in male mice of C57BL/6N substrains in multiple international mouse facilities. PLoS One. 2020; 15(6):e0230162. doi: 10.1371/journal.pone.0230162 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Eulderink F, Ivanyi P, Weinreich S. Histopathology of murine ankylosing enthesopathy. Pathology Research and Practice. 1998;194(11):797–803. doi: 10.1016/S0344-0338(98)80070-8 [DOI] [PubMed] [Google Scholar]
  • 3.Walton M. A spontaneous ankle deformity in an inbred strain of mouse. J Pathol. 1978. Apr;124(4):189–94. doi: 10.1002/path.1711240403 [DOI] [PubMed] [Google Scholar]
  • 4.Sukoff Rizzo SJ, Anderson LC, Green TL, McGarr T, Wells G, Winter SS. Assessing Healthspan and Lifespan Measures in Aging Mice: Optimization of Testing Protocols, Replicability, and Rater Reliability. Curr Protoc Mouse Biol. 2018. Jun; 8(2):e45. doi: 10.1002/cpmo.45 [DOI] [PubMed] [Google Scholar]
  • 5.Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994. Jul;53(1):55–63. doi: 10.1016/0165-0270(94)90144-9 [DOI] [PubMed] [Google Scholar]
  • 6.Robinson I, Sargent B, Hatcher JP. Use of dynamic weight bearing as a novel end-point for the assessment of Freund’s Complete Adjuvant induced hypersensitivity in mice. Neurosci Lett. 2012. Aug 30;524(2):107–10. doi: 10.1016/j.neulet.2012.07.017 [DOI] [PubMed] [Google Scholar]
  • 7.Gades NM, Danneman PJ, Wixson SK, Tolley EA. The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. Contemp Top Lab Anim Sci. 2000. Mar;39(2):8–13. [PubMed] [Google Scholar]
  • 8.Mason RM, Chambers MG, Flannelly J, Gaffen JD, Dudhia J, Bayliss MT. The STR/ort mouse and its use as a model of osteoarthritis. Osteoarthritis Cartilage. 2001. Feb;9(2):85–91. doi: 10.1053/joca.2000.0363 [DOI] [PubMed] [Google Scholar]
  • 9.Staines KA, Poulet B, Wentworth DN, Pitsillides AA. The STR/ort mouse model of spontaneous osteoarthritis—an update. Osteoarthritis Cartilage. 2017;25(6):802–8. doi: 10.1016/j.joca.2016.12.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Weinreich S, Eulderink F, Capkova J, Pla M, Gaede K, Heesemann J, et al. HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Hum Immunol. 1995. Feb;42(2):103–15. doi: 10.1016/0198-8859(94)00034-n [DOI] [PubMed] [Google Scholar]
  • 11.Šinkorová Z, Čapková J, Niederlová J, Štěpánková R, Šinkora J. Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2k) male mice. Human Immunology. 2008. Dec;69(12):845–50. doi: 10.1016/j.humimm.2008.08.296 [DOI] [PubMed] [Google Scholar]
  • 12.Capkova J, Ivanyi P, Rehakova Z. Sexual dimorphism, but not testosterone itself, is responsible for ankylosing enthesitis of the ankle in B10.BR (H-2k) male mice. Annals of the Rheumatic Diseases. 2006. Jan;65(1):130–2. doi: 10.1136/ard.2005.039800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Weinreich S, Capkova J, Hoebe-Hewryk B, Boog C, Ivanyi P, Cross NR. Grouped caging predisposes male mice to ankylosing enthesopathy. Vol. 55, Ann Rheum Dis. 1996. doi: 10.1136/ard.55.9.645 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Meakin LB, Sugiyama T, Galea GL, Browne WJ, Lanyon LE, Price JS. Male mice housed in groups engage in frequent fighting and show a lower response to additional bone loading than females or individually housed males that do not fight. Bone [Internet]. 2013. May;54(1):113–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23356987 doi: 10.1016/j.bone.2013.01.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nagy TR, Krzywanski D, Li J, Meleth S, Desmond R. Effect of group vs. single housing on phenotypic variance in C57BL/6J mice. Obes Res. 2002. May;10(5):412–5. doi: 10.1038/oby.2002.57 [DOI] [PubMed] [Google Scholar]
  • 16.Capkova J, Hrncir T, Kubatova A, Tlaskalova-Hogenova H. Lipopolysaccharide treatment suppresses spontaneously developing ankylosing enthesopathy in B10.BR male mice: The potential role of interleukin-10. BMC Musculoskeletal Disorders. 2012;13. doi: 10.1186/1471-2474-13-110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Russell WMS, Burch RL. The principles of humane experimental technique. London: Methuen & Co.; 1959. [Google Scholar]

Decision Letter 0

Jianhong Zhou

19 Dec 2022

PONE-D-22-26026Evaluation of Tarsal Injuries in C57BL/6J Male MicePLOS ONE

Dear Dr. Kick,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Specifically, both reviewers raised significant concerns that need your attention. Please have all to comments addressed. 

Please submit your revised manuscript by Jan 16 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jianhong Zhou

Staff Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: November 15, 2022

Plos One Manuscript Review

Title: Evaluation of Tarsal Injuries in C57BL/6J Male Mice (PONE-D-22-26026)

Authors: Brenda Kick et al.

Summary and Comments: In this manuscript, the authors expand on previous reports of unilateral tarsal abnormalities found in a small subset of C57BL/6N, STR/ort, and B10.BR mice. The authors report that 1% of C57BL/6J male mice similarly display tarsal abnormalities by microCT and histological analyses. Furthermore, the authors go on to show that affected mice are responsive to morphine with regards to motor performance, suggesting that they experience pain as a result of tarsal abnormalities. Interestingly, these features were not observed in females or individually housed male mice indicating that they may be associated with unique behavior in male mice.

Overall, this study provides additional information on a subpopulation of mouse strains with spontaneous unilateral tarsal abnormalities, particularly in older C57BL/6J male mice which may impact data interpretation when using this mouse strain. One of the main concerns is that the manuscript appears to be incompletely written in its current form as the figures are not fully described in the text throughout the results section. In addition, it is unclear whether the phenotypes described are representative as there is little quantification of the morphological or histopathological data. Lastly, the manuscript should clearly state in the abstract and discussion (not just the introduction) that the unilateral tarsal abnormalities found in C57BL/6J mice are found only in a small portion of animals. The reviewer recommends that these issues be addressed prior to consideration for publication.

Other Comments:

In both the abstract and results section, it should be clearly stated that the spontaneous tarsal aberrations that the authors are describing are observed only a small population of mice, similar to what is stated in Line 62-63 (“Abnormal tarsal joints were noted in older male mice of the C57BL/6J lineage, around the age of 20 weeks or older, at a frequency of 1% of the population”).

Line 56, Authors’ description of the tarsal abnormalities, “ranging from 1.7% up to 12%, and beginning from 4 weeks of age to 78 weeks” seems very broad and random. If more information is available, it would be helpful to the reader if the authors discussed whether the rate of tarsal abnormalities are associated with age, sex, etc.

Line 127-128, it is mentioned that histological sections for the lumbar spine, coxofemoral joint, and TMJ were generated but the data is nowhere to be found. Either include the data or remove the description in the Methods section.

Line 138, more details on the Frailty composite testing method is needed to help readers understand how the experiment was actually performed.

In Fig 1, Readers will find it helpful if the hindfoot joint abnormality is indicated with an arrow or outlined to show the extent of the curvature.

Line 199, Do the authors have data to demonstrate that “Mice with this joint abnormality have an inability to fully extend the joint…walking more on the metatarsals of the foot”?

In Fig 2, dotted arrows should be edited to enhance visibility.

Line 205-210, There is no mention of Fig 2A or 2C-E in the results section. Also applicable to other figures throughout the manuscript.

Line 227-230, histological description is difficult to confirm due to the low resolution of images presented. Changes in proliferation, osteophyte formation, synovial inflammation should be quantified or assessed by histological scoring accompanied by statistical analysis.

Line 234, asterisk is marking the talus in the actual figure. The star is marking calcaneus but is not described in the figure legend.

Line 239, higher resolution images, proper staining (e.g., Safranin-O, etc.) and quantification are needed to show the presence or absence of damage to the articular cartilage.

Line 363-366, there is no basis for the claim that calcaneal dislocation is the underlying cause of tarsal pathology.

Reviewer #2: This interesting study explores the occurrence of tarsal injuries in the C57BL/6J mouse strain (males only). While the initial characterization provides exciting data that corroborates some of the authors' claims, additional analyses are needed to reach the conclusions presented in the manuscript.

First, histological features highlighted in the text, including tarsal necrosis, synovial hyperplasia, periosteal proliferation, osteophytes, and fibrocartilagenous formations within ligaments, are poorly captured in the Figures in large part due to a lack of appropriate histological staining and high-magnification images. At a minimum, the authors should utilize stains that evaluate the integrity of the ECM, particularly in synovial compartments, ligaments and tendons of the foot (including Achilles tendon), bone, and cartilage. Stains such as safranin-O/fast green or toluidine blue for cartilage, picosirius red to evaluate collagen alignment by polarized light microscopy, and Masson's trichrome should be performed. Sections that include the Achilles tendon should also be shown in addition to the ones provided, and higher magnification images of the site of dislocation, especially the areas of aberrant ECM deposition seen adjacent to the calcaneal displacement, should be included. Low and high-res photos should be provided side-by-side for normal and affected mice.

The available microCT data provided is compelling but under-analyzed. In particular, could joint space narrowing be quantified and/or bone mineral density of affected bones in the foot? Also, how is the shape of the bones affected compared to mice without the deformity - could this be quantified in some way?

The use of a frailty score comprising 27 individual observational scores is uninformative. The authors should present these 27 scores individually in a Table to accompany the combined Frailty Score given in Figure 4, along with the appropriate statistical tests for each. In addition, how they were collected, including room conditions, the gender of the observer, whether the observer was blinded, and whether multiple observers were used, should be included in the Methods section. This type of information should be added for all behavioural assays used.

Overall, the behavioural data is interesting, and the pain contribution is compelling based on the analysis of Morphine administration. However, have the authors evaluated whether the innervation of the foot is altered? Or is inflammation elevated in affected animals?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Jun 26;18(6):e0287204. doi: 10.1371/journal.pone.0287204.r002

Author response to Decision Letter 0


19 May 2023

Comments:

In both the abstract and results section, it should be clearly stated that the spontaneous tarsal aberrations that the authors are describing are observed only a small population of mice, similar to what is stated in Line 62-63 (“Abnormal tarsal joints were noted in older male mice of the C57BL/6J lineage, around the age of 20 weeks or older, at a frequency of 1% of the population”).

Please note updated lines 31-33, 209-210, and 363-364 to address this concern.

Line 56, Authors’ description of the tarsal abnormalities, “ranging from 1.7% up to 12%, and beginning from 4 weeks of age to 78 weeks” seems very broad and random. If more information is available, it would be helpful to the reader if the authors discussed whether the rate of tarsal abnormalities are associated with age, sex, etc.

The exact reasoning for the broad and random differences that were noted within the International Mouse Phenotyping Consortium is unknown. It was hypothesized in the paper that potentially it may be due to animal housing and husbandry practice differences. I added further clarification in the text and potential other hypotheses to why the difference exists in lines 61-66.

Line 127-128, it is mentioned that histological sections for the lumbar spine, coxofemoral joint, and TMJ were generated but the data is nowhere to be found. Either include the data or remove the description in the Methods section.

Description removed from Methods section

Line 138, more details on the Frailty composite testing method is needed to help readers understand how the experiment was actually performed.

Please see additional Supplement 2 Table provided to the readers.

In Fig 1, Readers will find it helpful if the hindfoot joint abnormality is indicated with an arrow or outlined to show the extent of the curvature.

Please note that there are now red and black arrows highlighting the hind foot joint abnormality.

Line 199, Do the authors have data to demonstrate that “Mice with this joint abnormality have an inability to fully extend the joint…walking more on the metatarsals of the foot”?

This was a clinically observed phenomenon, no data exists. Figure 1 does show that the metatarsals are more planted on the ground compared to the normal mouse in the image. Please see further description in results lines 209-214.

In Fig 2, dotted arrows should be edited to enhance visibility.

Line 205-210, There is no mention of Fig 2A or 2C-E in the results section. Also applicable to other figures throughout the manuscript.

Corrected in the respective results sections lines 224-231.

Line 227-230, histological description is difficult to confirm due to the low resolution of images presented. Changes in proliferation, osteophyte formation, synovial inflammation should be quantified or assessed by histological scoring accompanied by statistical analysis.

See updated Figure 3. Note we did not pursue a histologic scoring mechanism as most of the grading systems out there are for the knee (one large joint) compared to the tarsus (multiple small joints). There is also not a good view of all of the small joints in the tarsus due to the function of the cut, making scoring difficult.

Line 234, asterisk is marking the talus in the actual figure. The star is marking calcaneus but is not described in the figure legend.

Corrected in lines 260-261

Line 239, higher resolution images, proper staining (e.g., Safranin-O, etc.) and quantification are needed to show the presence or absence of damage to the articular cartilage.

See updated image 3. We added views with Safranin-O stain. We didn’t get to show images that we obtained with Trichrome stains due to folds being present in the cut.

Line 363-366, there is no basis for the claim that calcaneal dislocation is the underlying cause of tarsal pathology.

See updated line 393.

Reviewer #2: This interesting study explores the occurrence of tarsal injuries in the C57BL/6J mouse strain (males only). While the initial characterization provides exciting data that corroborates some of the authors' claims, additional analyses are needed to reach the conclusions presented in the manuscript.

First, histological features highlighted in the text, including tarsal necrosis, synovial hyperplasia, periosteal proliferation, osteophytes, and fibrocartilagenous formations within ligaments, are poorly captured in the Figures in large part due to a lack of appropriate histological staining and high-magnification images. At a minimum, the authors should utilize stains that evaluate the integrity of the ECM, particularly in synovial compartments, ligaments and tendons of the foot (including Achilles tendon), bone, and cartilage. Stains such as safranin-O/fast green or toluidine blue for cartilage, picosirius red to evaluate collagen alignment by polarized light microscopy, and Masson's trichrome should be performed. Sections that include the Achilles tendon should also be shown in addition to the ones provided, and higher magnification images of the site of dislocation, especially the areas of aberrant ECM deposition seen adjacent to the calcaneal displacement, should be included. Low and high-res photos should be provided side-by-side for normal and affected mice.

The available microCT data provided is compelling but under-analyzed. In particular, could joint space narrowing be quantified and/or bone mineral density of affected bones in the foot? Also, how is the shape of the bones affected compared to mice without the deformity - could this be quantified in some way?

We were not able to analyze the microCT data further as it is fell outside the scope of this paper.

The use of a frailty score comprising 27 individual observational scores is uninformative. The authors should present these 27 scores individually in a Table to accompany the combined Frailty Score given in Figure 4, along with the appropriate statistical tests for each. In addition, how they were collected, including room conditions, the gender of the observer, whether the observer was blinded, and whether multiple observers were used, should be included in the Methods section. This type of information should be added for all behavioural assays used.

Please see supplemental Table 2 for the frailty score information. Please note additional information was added in the methods section for providing further details on the behavioral tests. I would like to note that experimenters are validated within the team.

Overall, the behavioural data is interesting, and the pain contribution is compelling based on the analysis of Morphine administration. However, have the authors evaluated whether the innervation of the foot is altered? Or is inflammation elevated in affected animals?

We were not able to evaluate either the inflammation or innervation in the scope of this paper, but the author thanks the reviewer for these additional thoughts.

Decision Letter 1

Joohyun Lim

1 Jun 2023

Evaluation of Tarsal Injuries in C57BL/6J Male Mice

PONE-D-22-26026R1

Dear Dr. Brenda Kick,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Joohyun Lim

Guest Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The authors have addressed all major concerns. It would still be helpful to show the behavioural metrics separately as opposed to together in a cumulative score, but it is not necessary for acceptance at this time.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Acceptance letter

Joohyun Lim

15 Jun 2023

PONE-D-22-26026R1

Evaluation of Tarsal Injuries in C57BL/6J Male Mice

Dear Dr. Kick:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Joohyun Lim

Guest Editor

PLOS ONE


Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES